Aton Ra Partners Ultragenyx Pharmaceutical Inc. Transaction History

Aton Ra Partners

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 16, 2022	SELL	$62.2 - $84.4 $745,467 - $1.01 Million	-11,985 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$73.71 - $87.86 $87,125 - $103,850	1,182 Added 10.94%	11,985 $1.01 Million
Q3 2021 Nov 15, 2021	BUY	$77.92 - $102.4 $49,712 - $65,331	638 Added 6.28%	10,803 $974,000
Q2 2021 Aug 12, 2021	SELL	$92.19 - $115.71 $1 Million - $1.26 Million	-10,852 Reduced 51.63%	10,165 $969,000
Q1 2021 May 17, 2021	BUY	$106.9 - $167.73 $360,359 - $565,417	3,371 Added 19.1%	21,017 $2.39 Million
Q4 2020 Feb 19, 2021	BUY	$84.4 - $177.39 $1.49 Million - $3.13 Million	17,646 New	17,646 $2.44 Million

325

85.6M

520K

406K

Ticker RARE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 70,036,896
Market Cap $3.1B
Description
Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in North America, Europe, and internationally. Its biologic products include Crysvita (burosumab), an antibody targeting fibroblast...

Get notified when there are updates to the investment portfolio of Aton Ra Partners, based on Form 13F filings with the SEC.

Stay updated on Aton Ra Partners with notifications on news.